Evidence map›Paper›PMID 38532960›Full record

ArticleOpen forum infectious diseases2024

Jie Liu, Paul F Garcia Bardales, Kamrul Islam, Sheikh Jarju, Jane Juma, Chimwemwe Mhango, Queen Naumanga, Sonia Qureshi, Catherine Sonye, Naveed Ahmed and 38 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Burden ofBMJ global health · 2026
    Pooled it
  2. Article
  3. Effects ofmedRxiv : the preprint server for health sciences · 2026
    Article
  4. The consequences ofEClinicalMedicine · 2026
    Article
  5. Article
  6. The Burden and Genomic Characterization ofmedRxiv : the preprint server for health sciences · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Shigellosis.Lancet (London, England) · 2025
    Review
  14. Article
  15. Twenty-five years of sentinel laboratory-based surveillance of shigellosis in a high-income country endemic for the disease, Israel, 1998 to 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  16. Article
  17. Article
  18. Quantifying the Cost ofOpen forum infectious diseases · 2024
    Article
  19. Article
  20. Exploring Natural Immune Responses toOpen forum infectious diseases · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors.

Jie LiuSchool of Public Health, Qingdao University, Qingdao, China.
Paul F Garcia BardalesAsociación Benéfica PRISMA, Iquitos, Loreto, Peru.
Kamrul IslamInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh  (icddr,b), Dhaka, Bangladesh.
Sheikh JarjuMedical Research Council Unit The Gambia, London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Jane JumaCentre pour le Développement des Vaccins du Mali  (CVD-Mali), Bamako, Mali.
Chimwemwe MhangoMalawi Liverpool Wellcome Research Programme, Blantyre, Malawi.
Queen NaumangaDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Sonia QureshiDepartment of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Catherine SonyeCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Naveed AhmedDepartment of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Fatima AzizDepartment of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Md Taufiqur Rahman BhuiyanInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh  (icddr,b), Dhaka, Bangladesh.
Mary CharlesMalawi Liverpool Wellcome Research Programme, Blantyre, Malawi.
Nigel A CunliffeInstitute of Infection, Veterinary and Ecological Sciences, Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, United Kingdom.
Mahamadou AbdouCentre pour le Développement des Vaccins du Mali  (CVD-Mali), Bamako, Mali.
Sean R GalaganDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Ensa GittehMedical Research Council Unit The Gambia, London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Ibrehima GuindoCentre pour le Développement des Vaccins du Mali  (CVD-Mali), Bamako, Mali.
M Jahangir HossainMedical Research Council Unit The Gambia, London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Abdoulie M J JabangMedical Research Council Unit The Gambia, London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Khuzwayo C JereMalawi Liverpool Wellcome Research Programme, Blantyre, Malawi.
Flywell KawongaMalawi Liverpool Wellcome Research Programme, Blantyre, Malawi.
Mariama KeitaMedical Research Council Unit The Gambia, London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Noumou Yakhouba KeitaCentre pour le Développement des Vaccins du Mali  (CVD-Mali), Bamako, Mali.
Karen L KotloffCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Wagner V Shapiama LopezAsociación Benéfica PRISMA, Iquitos, Loreto, Peru.
Stephen MungaCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Maribel Paredes OlorteguiAsociación Benéfica PRISMA, Iquitos, Loreto, Peru.
Richard OmoreCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Patricia B PavlinacDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Firdausi QadriInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh  (icddr,b), Dhaka, Bangladesh.
Farah Naz QamarDepartment of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
S M Azadul Alam RazInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh  (icddr,b), Dhaka, Bangladesh.
Laura RizikiCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Francesca SchiaffinoDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Suzanne StroupDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Sarata Nassoun TraoreCentre pour le Développement des Vaccins du Mali  (CVD-Mali), Bamako, Mali.
Tackeshy Pinedo VasquezAsociación Benéfica PRISMA, Iquitos, Loreto, Peru.
Mohammad Tahir YousafzaiDepartment of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Martin AntonioMedical Research Council Unit The Gambia, London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Jennifer E CornickMalawi Liverpool Wellcome Research Programme, Blantyre, Malawi.
Furqan KabirDepartment of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Farhana KhanamInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh  (icddr,b), Dhaka, Bangladesh.
Margaret N KosekDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
John Benjamin OchiengCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
James A Platts-MillsDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Sharon M TennantCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Eric R HouptDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.

Funding

Enabling Infectious Disease Research Capacity in the Peruvian AmazonD43TW010913 · FIC · UNIVERSITY OF VIRGINIA · PI Margaret N Kosek, MARIBEL PAREDES OLORTEGUI · 2018 to 2026
$2.8M
Genomic Epidemiology of Campylobacter in Poultry to Enable the Effective Control of Human Campylobacteriosis in a Middle Income CountryK43TW012298 · FIC · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI Francesca Schiaffino · 2022 to 2026
$811k
FIC NIH HHS D43 TW010913FIC NIH HHS K43 TW012298Gates Foundation INV-028721Gates Foundation INV-031791Gates Foundation INV-041730
6 · The paper itself

Abstract

Background: Quantitative polymerase chain reaction (qPCR) targeting Methods: The Enterics for Global Health (EFGH) Conclusions: TAC enables simultaneous detection of diarrheal etiologies, the principal pathogen subtypes, and AMR genes. The high sensitivity of the assay enables more accurate estimation of

Indexed as

ipaHPCRquantificationrectal swabserotyping

Identifiers

PMID38532960
PMCPMC10962731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.